Infinavir generic name Duvarizumab Injection has anti-tumor effects and efficacy, and the medication should be used in accordance with the doctor’s instructions. Duvarizumab Injection is a human immunoglobulin G1kappa (IgG1κ) monoclonal antibody, which can block programmed cell death ligand-1 (PD-L1) to increase in vitro T-cell activation, resulting in a reduction in tumor size. The drug is indicated for the treatment of patients with unresectable stage III non-small cell lung cancer who have not experienced disease progression following platinum-based chemotherapy with concurrent radiotherapy. Contraindications to the use of the drug are not known. The most common adverse reactions following administration include cough, non-infectious pneumonia, radiation pneumonitis, upper respiratory tract infection, dyspnea, fatigue and rash. Specific medication should be administered under the supervision of a specialist.